APA (7th ed.) Citation

HY, L., SC, H., TY, P., FJ, L., & CC, W. (2025). Plasma Concentrations of Prophylactic Posaconazole and Risk Factors for Subtherapeutic Exposure in Taiwanese Patients with Hematologic Malignancies. Drug design, development and therapy, 19, 11941. https://doi.org/10.2147/DDDT.S557802

Chicago Style (17th ed.) Citation

HY, Lin, Hu SC, Pai TY, Lin FJ, and Wu CC. "Plasma Concentrations of Prophylactic Posaconazole and Risk Factors for Subtherapeutic Exposure in Taiwanese Patients with Hematologic Malignancies." Drug Design, Development and Therapy 19 (2025): 11941. https://doi.org/10.2147/DDDT.S557802.

MLA (9th ed.) Citation

HY, Lin, et al. "Plasma Concentrations of Prophylactic Posaconazole and Risk Factors for Subtherapeutic Exposure in Taiwanese Patients with Hematologic Malignancies." Drug Design, Development and Therapy, vol. 19, 2025, p. 11941, https://doi.org/10.2147/DDDT.S557802.